Study List


Study List

Clinical Studies

NCT Number Gene Therapy Sponsor Status Brief Title Phase View
NCT00003569 Roswell Park Cancer Institute COMPLETED Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel View
NCT00003568 University of Illinois at Chicago COMPLETED Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma PHASE2 View
NCT00003567 Possible Gene Therapy Case Comprehensive Cancer Center TERMINATED Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma PHASE1 View
NCT00003566 Alliance for Clinical Trials in Oncology COMPLETED Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer NA View
NCT00003561 Positive Gene Therapy Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins TERMINATED Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia PHASE2 View
NCT00003560 Herbert Irving Comprehensive Cancer Center UNKNOWN Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE2 View
NCT00003558 Academisch Ziekenhuis Maastricht UNKNOWN Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin PHASE3 View
NCT00003557 University of Chicago COMPLETED Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer PHASE2 View
NCT00003556 National Cancer Institute (NCI) COMPLETED Vaccine Therapy in Treating Patients With Melanoma PHASE1 View
NCT00003551 Emory University COMPLETED Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer PHASE2 View
NCT00003535 Burzynski Research Institute TERMINATED Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma PHASE2 View
NCT00003534 Burzynski Research Institute WITHDRAWN Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer PHASE2 View
NCT00003533 Burzynski Research Institute TERMINATED Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer PHASE2 View
NCT00003532 Burzynski Research Institute TERMINATED Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer PHASE2 View
NCT00003528 National Cancer Institute (NCI) COMPLETED Raltitrexed in Treating Children With Refractory Acute Leukemia PHASE1 View
NCT00003520 Burzynski Research Institute TERMINATED Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer PHASE2 View
NCT00003518 Eastern Cooperative Oncology Group COMPLETED Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors PHASE2 View
NCT00003512 Burzynski Research Institute WITHDRAWN Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia PHASE2 View
NCT00003508 Burzynski Research Institute TERMINATED Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma PHASE2 View
NCT00003505 Burzynski Research Institute WITHDRAWN Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma PHASE2 View
NCT00003502 Burzynski Research Institute WITHDRAWN Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma PHASE2 View
NCT00003495 Burzynski Research Institute TERMINATED Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer PHASE2 View
NCT00003494 Positive Gene Therapy Burzynski Research Institute TERMINATED Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer PHASE2 View
NCT00003493 The Cleveland Clinic COMPLETED Combination Chemotherapy in Treating Patients With Multiple Myeloma PHASE2 View
NCT00003492 Burzynski Research Institute TERMINATED Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer PHASE2 View
NCT00003469 Burzynski Research Institute TERMINATED Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System PHASE2 View
NCT00003468 Burzynski Research Institute COMPLETED Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma PHASE2 View
NCT00003467 Duke University COMPLETED Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma PHASE2 View
NCT00003466 Duke University COMPLETED Temozolomide in Treating Patients With Progressive Low-Grade Glioma PHASE2 View
NCT00003461 Duke University COMPLETED Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors PHASE1 View
NCT00003460 Burzynski Research Institute COMPLETED Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors PHASE2 View
NCT00003459 Burzynski Research Institute COMPLETED Antineoplaston Therapy in Treating Patients With Brain Stem Glioma PHASE2 View
NCT00003458 Burzynski Research Institute COMPLETED Antineoplaston Therapy in Treating Children With Brain Tumors PHASE2 View
NCT00003457 Positive Gene Therapy Burzynski Research Institute COMPLETED Antineoplaston Therapy in Treating Patients With Brain Tumors PHASE2 View
NCT00003456 Burzynski Research Institute COMPLETED Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme PHASE2 View
NCT00003451 National Cancer Institute (NCI) COMPLETED Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer PHASE1 View
NCT00003450 University of Texas Southwestern Medical Center COMPLETED Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer PHASE1 View
NCT00003435 Duke University WITHDRAWN Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer PHASE1 View
NCT00003434 Duke University TERMINATED Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer PHASE1 View
NCT00003433 Duke Cancer Institute COMPLETED Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer PHASE1 View
NCT00003432 Duke University TERMINATED Immunotherapy in Treating Patients With Metastatic Breast Cancer PHASE1 View
NCT00003420 Medical Research Council COMPLETED CT Scans in Treating Patients With Stage I Testicular Cancer After Undergoing Orchiectomy NA View
NCT00003418 International Collaborative Cancer Group UNKNOWN Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer PHASE3 View
NCT00003416 SWOG Cancer Research Network COMPLETED S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia PHASE2 View
NCT00003406 Positive Gene Therapy Cancer Treatment Centers of America COMPLETED Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer PHASE1 View
NCT00003405 Rush University Medical Center WITHDRAWN Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia PHASE2 View
NCT00003404 Dartmouth-Hitchcock Medical Center COMPLETED Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast NA View
NCT00003403 Gem Pharmaceuticals COMPLETED GPX-100 in Treating Patients With Solid Tumors PHASE1 View
NCT00003402 University of Maryland, Baltimore COMPLETED Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia PHASE2 View
NCT00003400 University of Maryland, Baltimore COMPLETED Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer PHASE2 View
NCT00003395 Memorial Sloan Kettering Cancer Center COMPLETED Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer PHASE1 View
NCT00003394 Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer PHASE1 View
NCT00003392 UNC Lineberger Comprehensive Cancer Center COMPLETED High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer PHASE2 View
NCT00003369 SWOG Cancer Research Network COMPLETED S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer PHASE2 View
NCT00003368 National Cancer Institute (NCI) COMPLETED Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis PHASE1 View
NCT00003367 Memorial Sloan Kettering Cancer Center COMPLETED Diet and PSA Levels in Patients With Prostate Cancer PHASE3 View
NCT00003361 Positive Gene Therapy Memorial Sloan Kettering Cancer Center COMPLETED Decitabine in Treating Patients With Myelodysplastic Syndrome PHASE2 View
NCT00003360 Memorial Sloan Kettering Cancer Center COMPLETED Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer PHASE1 View
NCT00003359 Memorial Sloan Kettering Cancer Center COMPLETED T138067 Sodium in Treating Patients With Advanced Refractory Cancer PHASE1 View
NCT00003358 Memorial Sloan Kettering Cancer Center COMPLETED Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer PHASE1 View
NCT00003357 Memorial Sloan Kettering Cancer Center COMPLETED Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease PHASE1 View
NCT00003356 University of Rochester COMPLETED Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma PHASE1 View
NCT00003351 Alliance for Clinical Trials in Oncology COMPLETED Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer PHASE2 View
NCT00003350 National Cancer Institute (NCI) COMPLETED Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma PHASE3 View
NCT00003335 Case Comprehensive Cancer Center COMPLETED Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer PHASE2 View
NCT00003334 NYU Langone Health COMPLETED Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract PHASE2 View
NCT00003332 NYU Langone Health COMPLETED Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer PHASE1 View
NCT00003320 Jonsson Comprehensive Cancer Center COMPLETED Radiation Therapy Following Surgery to Remove Brain Metastases NA View
NCT00003312 Radiation Therapy Oncology Group COMPLETED Brachytherapy in Treating Patients With Prostate Cancer PHASE2 View
NCT00003305 Genzyme, a Sanofi Company COMPLETED Aminopterin in Treating Patients With Refractory Leukemia PHASE2 View
NCT00003304 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors PHASE2 View
NCT00003302 Abramson Cancer Center at Penn Medicine COMPLETED MRI to Detect Breast Tumors in Women NA View
NCT00003294 Roswell Park Cancer Institute COMPLETED Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer PHASE1 View
NCT00003293 Pfizer COMPLETED SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme PHASE3 View
NCT00003292 SWOG Cancer Research Network TERMINATED S9624 Ifosfamide in Treating Patients With Meningeal Tumors PHASE2 View
NCT00003269 Scripps Health COMPLETED Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors PHASE2 View
NCT00003268 Sidney Kimmel Cancer Center at Thomas Jefferson University COMPLETED Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia PHASE1 View
NCT00003267 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer PHASE3 View
NCT00003266 Positive Gene Therapy Eastern Cooperative Oncology Group COMPLETED Methylphenidate in Treating Patients With Melanoma PHASE3 View
NCT00003261 Centro di Riferimento Oncologico - Aviano UNKNOWN Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma PHASE2 View
NCT00003260 GERCOR - Multidisciplinary Oncology Cooperative Group UNKNOWN Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer PHASE3 View
NCT00003259 Swiss Cancer Institute COMPLETED Vinorelbine in Treating Patients With Metastatic Prostate Cancer PHASE2 View
NCT00003257 Aventis Pharmaceuticals UNKNOWN Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer PHASE2 View
NCT00003256 National Cancer Institute (NCI) COMPLETED Flavopiridol in Treating Patients With Recurrent Prostate Cancer PHASE2 View
NCT00003251 University of Illinois at Chicago UNKNOWN Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer PHASE1 View
NCT00003250 Barbara Ann Karmanos Cancer Institute COMPLETED Fenretinide in Treating Patients With Solid Tumors PHASE1 View
NCT00003235 Eastern Cooperative Oncology Group COMPLETED Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed PHASE3 View
NCT00003234 Children's Oncology Group COMPLETED Vinorelbine in Treating Children With Recurrent or Refractory Cancers PHASE2 View
NCT00003232 NCIC Clinical Trials Group COMPLETED Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer PHASE3 View
NCT00003220 Barbara Ann Karmanos Cancer Institute COMPLETED Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer PHASE2 View
NCT00003206 Positive Gene Therapy Eastern Cooperative Oncology Group COMPLETED Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer PHASE2 View
NCT00003205 University of Colorado, Denver COMPLETED Bryostatin 1 in Treating Patients With Stage IV Breast Cancer PHASE2 View
NCT00003204 National Cancer Institute (NCI) COMPLETED Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma PHASE3 View
NCT00003203 Positive Gene Therapy Children's Oncology Group COMPLETED Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors PHASE2 View
NCT00003202 Wake Forest University Health Sciences COMPLETED Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer PHASE1 View
NCT00003195 Fred Hutchinson Cancer Center COMPLETED Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma PHASE2 View
NCT00003194 Seattle Children's Hospital TERMINATED Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors PHASE1 View
NCT00003193 Massachusetts General Hospital COMPLETED Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer PHASE1 View
NCT00003192 University of Chicago COMPLETED Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus PHASE2 View
NCT00003167 National Cancer Institute (NCI) COMPLETED Gene Therapy in Treating Patients With Advanced Bladder Cancer PHASE1 View
NCT00003166 National Cancer Institute (NCI) COMPLETED Bryostatin and Vincristine in B-Cell Malignancies PHASE1 View
NCT00003160 Theradex UNKNOWN Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum PHASE2 View
NCT00003159 Medical Research Council COMPLETED Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer PHASE3 View
NCT00003158 SWOG Cancer Research Network COMPLETED S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer PHASE2 View
NCT00003157 Alliance for Clinical Trials in Oncology COMPLETED Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach PHASE1 View
NCT00003156 Gynecologic Oncology Group TERMINATED Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus PHASE2 View
NCT00003151 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma PHASE2 View
NCT00003150 Eastern Cooperative Oncology Group COMPLETED Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma PHASE3 View
NCT00003135 The University of Texas Health Science Center, Houston UNKNOWN Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer PHASE2 View
NCT00003134 Alliance for Clinical Trials in Oncology COMPLETED Irinotecan in Treating Patients With Recurrent Glioma PHASE2 View
NCT00003133 Positive Gene Therapy Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer PHASE1 View
NCT00003132 Positive Gene Therapy NYU Langone Health COMPLETED Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer PHASE1 View
NCT00003120 SWOG Cancer Research Network COMPLETED S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission PHASE3 View
NCT00003118 Alliance for Clinical Trials in Oncology COMPLETED Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus PHASE3 View
NCT00003105 Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer PHASE1 View
NCT00003104 Memorial Sloan Kettering Cancer Center COMPLETED Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer PHASE2 View
NCT00003103 Memorial Sloan Kettering Cancer Center COMPLETED Chemotherapy in Treating Patients With Solid Tumors PHASE1 View
NCT00003102 Ludwig Institute for Cancer Research COMPLETED Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer PHASE1 View
NCT00003095 SWOG Cancer Research Network COMPLETED S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer View
NCT00003094 University of California, San Diego WITHDRAWN Carotenoid Rich Diet in Treating Cervical Dysplasia PHASE2 View
NCT00003093 Children's Oncology Group COMPLETED Combination Chemotherapy in Treating Children With Neuroblastoma PHASE3 View
NCT00003092 Alliance for Clinical Trials in Oncology COMPLETED Paclitaxel in Treating Older Patients With Solid Tumors PHASE3 View
NCT00003068 University of Arizona COMPLETED High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer PHASE2 View
NCT00003067 Weill Medical College of Cornell University SUSPENDED Biological Therapy in Treating Patients With Primary or Advanced Glioma PHASE2 View
NCT00003066 Herbert Irving Comprehensive Cancer Center UNKNOWN Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer PHASE2 View
NCT00003061 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma PHASE2 View
NCT00003060 Louisiana State University Health Sciences Center Shreveport TERMINATED Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma PHASE1 View
NCT00003058 Dana-Farber Cancer Institute COMPLETED Troglitazone in Treating Patients With Liposarcoma PHASE2 View
NCT00003057 Eastern Cooperative Oncology Group COMPLETED Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer PHASE3 View
NCT00003056 Baxalta now part of Shire TERMINATED Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation PHASE3 View
NCT00003050 University of Southern California COMPLETED Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer PHASE2 View
NCT00003035 Georgetown University COMPLETED Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer PHASE2 View
NCT00003034 Positive Gene Therapy Alfacell UNKNOWN ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen PHASE3 View
NCT00003032 NCIC Clinical Trials Group COMPLETED High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer PHASE3 View
NCT00003027 Eastern Cooperative Oncology Group COMPLETED Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma PHASE3 View
NCT00003020 Duke University COMPLETED LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases PHASE1 View
NCT00003018 SWOG Cancer Research Network COMPLETED S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer PHASE2 View
NCT00003006 Alliance for Clinical Trials in Oncology COMPLETED Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer View
NCT00003005 Boston Medical Center COMPLETED Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia PHASE1 View
NCT00003004 Memorial Sloan Kettering Cancer Center COMPLETED Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors PHASE1 View
NCT00003003 Dartmouth-Hitchcock Medical Center COMPLETED Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia PHASE1 View
NCT00003002 University of Washington COMPLETED HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer PHASE1 View
NCT00002995 Children's Oncology Group COMPLETED Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma PHASE3 View
NCT00002994 Alliance for Clinical Trials in Oncology COMPLETED Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors PHASE1 View
NCT00002993 Gynecologic Oncology Group TERMINATED Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus PHASE2 View
NCT00002969 SWOG Cancer Research Network COMPLETED S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer PHASE2 View
NCT00002968 National Cancer Institute (NCI) COMPLETED Edrecolomab in Treating Patients With Stage II Colon Cancer PHASE3 View
NCT00002967 NSABP Foundation Inc COMPLETED Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer PHASE3 View
NCT00002961 Children's Hospital of Philadelphia TERMINATED Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia PHASE3 View
NCT00002960 Merck Sharp & Dohme LLC COMPLETED SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) PHASE1 View
NCT00002956 University of Alabama at Birmingham WITHDRAWN Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants PHASE1 View
NCT00002951 University of Chicago COMPLETED Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer PHASE2 View
NCT00002950 Yale University COMPLETED Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer PHASE1 View
NCT00002935 Roswell Park Cancer Institute COMPLETED Photodynamic Therapy in Treating Patients With Early Esophageal Cancer PHASE2 View
NCT00002934 Eastern Cooperative Oncology Group TERMINATED Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ PHASE2 View
NCT00002933 Positive Gene Therapy Case Comprehensive Cancer Center COMPLETED Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer PHASE2 View
NCT00002932 Radiation Therapy Oncology Group COMPLETED Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck PHASE2 View
NCT00002920 SWOG Cancer Research Network COMPLETED S9630, Medroxyprogesterone in Treating Women With Breast Cancer PHASE3 View
NCT00002912 National Cancer Institute (NCI) COMPLETED Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia PHASE1 View
NCT00002905 Centro di Riferimento Oncologico - Aviano UNKNOWN Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma PHASE2 View
NCT00002904 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors PHASE1 View
NCT00002903 European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer PHASE2 View
NCT00002902 Abramson Cancer Center at Penn Medicine COMPLETED Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00002895 Medical Research Council COMPLETED Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer PHASE3 View
NCT00002894 Medical Research Council COMPLETED Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer PHASE3 View
NCT00002893 Medical Research Council UNKNOWN Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer PHASE3 View
NCT00002892 Institute of Cancer Research, United Kingdom COMPLETED Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma PHASE3 View
NCT00002869 Medical Research Council UNKNOWN Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia PHASE3 View
NCT00002868 Eastern Cooperative Oncology Group COMPLETED Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia PHASE3 View
NCT00002866 NCIC Clinical Trials Group COMPLETED Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer PHASE1 View
NCT00002860 SWOG Cancer Research Network COMPLETED SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma PHASE2 View
NCT00002858 Gustave Roussy, Cancer Campus, Grand Paris UNKNOWN Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer PHASE3 View
NCT00002851 European Organisation for Research and Treatment of Cancer - EORTC UNKNOWN Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed PHASE3 View
NCT00002850 Gary Morrow COMPLETED Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy PHASE3 View
NCT00002835 M.D. Anderson Cancer Center COMPLETED Combination Chemotherapy in Treating Patients With Lymphoma PHASE3 View
NCT00002833 M.D. Anderson Cancer Center COMPLETED Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia PHASE2 View
NCT00002832 M.D. Anderson Cancer Center COMPLETED Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia PHASE1 View
NCT00002827 Children's Oncology Group COMPLETED Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease PHASE3 View
NCT00002818 Virginia Commonwealth University COMPLETED High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies PHASE1 View
NCT00002806 Alliance for Clinical Trials in Oncology COMPLETED Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma PHASE2 View
NCT00002805 Positive Gene Therapy Children's Oncology Group COMPLETED Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE2 View
NCT00002804 Children's Oncology Group COMPLETED Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma PHASE2 View
NCT00002803 Children's Hospital Medical Center, Cincinnati COMPLETED Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma PHASE2 View
NCT00002802 Children's Hospital Medical Center, Cincinnati COMPLETED Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma PHASE3 View
NCT00002794 St. Jude Children's Research Hospital COMPLETED Carboplatin Plus Vincristine in Treating Children With Retinoblastoma PHASE2 View
NCT00002793 Johann Wolfgang Goethe University Hospital UNKNOWN Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer PHASE3 View
NCT00002792 Fred Hutchinson Cancer Center COMPLETED Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders PHASE2 View
NCT00002768 Alliance for Clinical Trials in Oncology COMPLETED Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission PHASE2 View
NCT00002767 GlaxoSmithKline UNKNOWN Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma PHASE3 View
NCT00002766 Memorial Sloan Kettering Cancer Center COMPLETED Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma PHASE3 View
NCT00002761 Columbia University WITHDRAWN Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia PHASE1 View
NCT00002760 Positive Gene Therapy Alliance for Clinical Trials in Oncology COMPLETED Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer PHASE3 View
NCT00002759 National Cancer Institute (NCI) COMPLETED Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma PHASE1 View
NCT00002757 Children's Oncology Group COMPLETED TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma PHASE3 View
NCT00002756 Children's Oncology Group COMPLETED Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia PHASE2 View
NCT00002751 Duke University COMPLETED Monoclonal Antibody Therapy in Treating Patients With Brain Metastases PHASE1 View
NCT00002750 Duke University COMPLETED Melphalan in Patients With Neoplastic Meningitis PHASE1 View
NCT00002735 SWOG Cancer Research Network TERMINATED SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue PHASE2 View
NCT00002734 National Cancer Institute (NCI) COMPLETED Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer PHASE1 View
NCT00002733 Positive Gene Therapy Hoag Memorial Hospital Presbyterian COMPLETED Biological Therapy in Treating Patients With Metastatic Cancer PHASE2 View